The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease-Reference-Cited by-同舟云学术

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease

Published:2018-04-02 Issue:1 Volume:245 Page:85-100
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol

Author:

Batista Andre F¹,Forny-Germano Leticia¹,Clarke Julia R²,Lyra e Silva Natalia M¹,Brito-Moreira Jordano¹,Boehnke Susan E³,Winterborn Andrew⁴,Coe Brian C³,Lablans Ann³,Vital Juliana F¹,Marques Suelen A⁵,Martinez Ana MB⁶,Gralle Matthias¹,Holscher Christian⁷,Klein William L⁸,Houzel Jean-Christophe⁹,Ferreira Sergio T¹¹⁰,Munoz Douglas P³,De Felice Fernanda G¹³^ORCID

Affiliation:

1. Institute of Medical Biochemistry Leopoldo de Meis; Federal University of Rio de Janeiro; Rio de Janeiro Brazil

2. School of Pharmacy; Federal University of Rio de Janeiro; Rio de Janeiro Brazil

3. Centre for Neuroscience Studies, Department of Biomedical and Molecular Sciences; Queen's University; Kingston Ontario Canada

4. Animal Care Service; Queen's University; Kingston Ontario Canada

5. Departament of Neurobiology; Fluminense Federal University; Niteroi Brazil

6. Department of Pathology, Faculty of Medicine; Hospital Universitário Clementino Fraga Filho, UFRJ; Rio de Janeiro Brazil

7. Division of Biomed and Life Sciences; Faculty of Health and Medicine Lancaster University; Lancaster UK

8. Department of Neurobiology; Northwestern University; Evanston Illinois USA

9. Institute of Biomedical Sciences; Federal University of Rio de Janeiro; Rio de Janeiro Brazil

10. Institute of Biophysics Carlos Chagas Filho; Federal University of Rio de Janeiro; Rio de Janeiro Brazil

Funder

Alzheimer Society Canada

Human Frontier Science Program

John Simon Guggenheim Memorial Foundation

Canadian Institutes of Health Research

Canada Research Chair Program and Brain Canada

National Institute for Translational Neuroscience (INNT/Brazil)

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.5056/fullpdf

Reference117 articles.

1. Association of diabetes mellitus and dementia: the Rotterdam study;Ott;Diabetologia,1996

2. Alzheimer's disease is type 3 diabetes - evidence reviewed;Monte;J Diabetes Sci Technol,2008

3. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?;Akter;Br J Clin Pharmacol,2011

4. Alzheimer's disease and insulin resistance: translating basic science into clinical applications;De Felice;J Clin Invest,2013

5. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers;Bomfim;J Clin Invest,2012

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring advancements in early detection of Alzheimer's disease with molecular assays and animal models;Ageing Research Reviews;2024-09

2. Tirzepatide shows neuroprotective effects via regulating brain glucose metabolism in APP/PS1 mice;Peptides;2024-09

3. Baicalein: A potential GLP-1R agonist improves cognitive disorder of diabetes through mitophagy enhancement;Journal of Pharmaceutical Analysis;2024-08

4. Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer’s disease-like pathology in hippocampal neuronal cells via the blocking of Ca2+/Calpain/Cdk5-mediated mitochondrial fragmentation;Scientific Reports;2024-07-08

5. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects;Frontiers in Pharmacology;2024-06-14